Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatic pipeline to identify potential therapeutic targets with subsequent isolation and characterization of novel human anti- DDR1 antibodies. | Sci Rep | 2026 | 42286049 | PubTator, text mining | PubMed |
| Discoidin domain receptor 1 (DDR1): An emerged novel mechanosensor. | Fundam Res | 2026 | 42272476 | PubTator, text mining | PubMed |
| An updated review of discoidin domain receptor 1 (DDR1) modulators (2020-present). | Expert Opin Ther Pat | 2026 | 42240164 | PubTator, text mining | PubMed |
| Assessing the de novo paradigm in sporadic early-onset Alzheimer disease trios. | Mol Psychiatry | 2026 | 42215639 | PubTator, text mining | PubMed |
| Antibody-drug conjugates in colorectal cancer: molecular design, preclinical advances, and translational challenges. | Cancer Chemother Pharmacol | 2026 | 42207299 | PubTator, text mining | PubMed |
| Dual targeting of chemoresistance and ferroptosis in gastric cancer: DDR1/VEGFR2 inhibitor K-13 synergizes with docetaxel from preclinical models to phase Ib/II clinical trial. | Cell Death Differ | 2026 | 42128929 | PubTator, text mining | PubMed |
| CRISPR and compound screens in a novel ex vivo tissue model identify DDR1 and ETA as regulators of cancer cell invasion. | Cell Mol Biol Lett | 2026 | 42092764 | PubTator, text mining | PubMed |
| Activating inflammation amplifiers in keloids: precise trafficking of DDR1 to bind with collagen I. | Br J Dermatol | 2026 | 42032912 | PubTator, text mining | PubMed |
Comment on 'Collagen I-discoidin domain receptor 1 (DDR1) signalling as a driver of keloid inflammation: mechanistic expansion of the adenosine diphosphate ribosylation factor 6-DDR1 axis': reply from authors. | Br J Dermatol | 2026 | 42032910 | PubTator, text mining | PubMed |
| DDR1 Promotes Immune Evasion in Colorectal Cancer by Orchestrating IL33-Mediated M2-like Polarization of Tumor-Associated Macrophages. | Cancer Immunol Res | 2026 | 41962054 | PubTator, text mining | PubMed |
| Inflammatory memory disables a DDR1 degradation checkpoint to enable pancreatic cancer growth. | bioRxiv | 2026 | 41959220 | PubTator, text mining | PubMed |
| Targeting the tripartite axis of immune-metabolic-spatial crosstalk to overcome therapy resistance in breast cancer. | Front Immunol | 2026 | 41948334 | PubTator, text mining | PubMed |
| Collagen I-discoidin domain receptor 1 (DDR1) signalling as a driver of keloid inflammation: mechanistic expansion of the adenosine diphosphate ribosylation factor 6-DDR1 axis. | Br J Dermatol | 2026 | 41934296 | PubTator, text mining | PubMed |
| Anticarcinogenic effects of miR-199a-loaded gold nanoparticles on hepatocellular carcinoma: in vitro study. | Sci Rep | 2026 | 41927705 | PubTator, text mining | PubMed |
| Docking of millions: accelerating a million-scale virtual screening using deep learning. | Brief Bioinform | 2026 | 41883032 | PubTator, text mining | PubMed |
| Collagen I-discoidin domain receptor 1 signalling promotes inflammation development during keloid formation. | Br J Dermatol | 2026 | 41858284 | PubTator, text mining | PubMed |
| Artificial intelligence for precision oncology from phenotyping and drug discovery to clinical translation. | Discov Oncol | 2026 | 41857437 | PubTator, text mining | PubMed |
| [Matrix metalloproteinases in pituitary adenoma invasiveness]. | Probl Endokrinol (Mosk) | 2026 | 41834597 | PubTator, text mining | PubMed |
| DDR2-COL11A1 Transcriptional Coupling as a Candidate Therapeutic Target in Colorectal Cancer: Integrative Transcriptomic and Deep Learning Validation. | Int J Mol Sci | 2026 | 41828724 | PubTator, text mining | PubMed |
| A new perspective on population genetics: Deciphering the relationship between genetic variants and disease prevalence in Psoriasis. | PLoS One | 2026 | 41824440 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=2